Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other most oversold S&P 500 stocks in 2024. Strong economic growth and the prospect of declining ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Speakers express continued concerns about health risks and preserving the La Jolla Bike Path, where a wireless project is ...

From clearing hazardous brush to using a new fire retardant, being ‘proactive’ is called crucial to ensuring residents’ ...

The Village Merchants Association board says it will issue a statement soon as Jodi Rudick, who has been accused of conflict ...

The learning center for kids ages 6-11 run by local resident and retired educator Mary Sue Lindsay offers daily challenges ...

To honor Hunter and his career, Salk will hold a symposium titled “50 Years of Rafting the River of Life” on Friday, Feb. 21.

mRNA-4157 is being tested in a 157-subject phase 2 alongside Merck's PD-1 checkpoint inhibitor Keytruda (pembrolizumab) as an adjuvant treatment after surgery for patients with melanoma who are at ...

In October, Merck took up an option on the personalised RNA-based cancer vaccine with an upfront payment of $250 million as part of a collaboration first agreed in 2016 and expanded in 2018.

During an R&D update yesterday Merck said it is hoping to claim eight new cardiovascular therapy approvals between now and 2030, for diseases like atherosclerosis, heart failure, pulmonary ...

Merck & Co has said building its cardiovascular medicines business is central to its strategy to manage the loss of patent protection of cancer juggernaut Keytruda in five years, and new studies ...